2021 Scientific Retreat- Session 2

Session 2: Therapeutic Degraders as New Class of Prostate Cancer Treatments 
Thursday, October 28, 2021 | 8:45 AM – 9:25 AM PST 

Moderator: Howard Soule, PhD, Prostate Cancer Foundation 

Targeting Enhancer Addiction in Prostate Cancer by Impeding Chromatin Accessibility 
Arul M. Chinnaiyan, MD, PhD, University of Michigan, Michigan Center for Translational Pathology 

Clinical Development of ARV-110, a Novel AR Degrader, in Prostate Cancer 
Debbie Chirnomas, MD, MPH, Arvinas, Inc.